NCT07659860

Brief Summary

The aim of the study is to assess if chronic cough leads to injury and remodelling of the airways. We plan to analyse bronchial injury and remodelling in patients with refractory chronic cough lasting longer than 12 month . Assessment of injury mediators will be performed in blood and bronchoalveolar lavage fluid. Remodelling features will be analysed based on chest CT scan and pathologic specimens. Injury of epithelium will be assessed in bronchial biopsy specimens. The relationship between the duration, severity of chronic cough, and bronchial inflammation, damage, remodelling will be analysed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
1mo left

Started Oct 2022

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Oct 2022Aug 2026

Study Start

First participant enrolled

October 1, 2022

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

June 15, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2026

Expected
Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

3.8 years

First QC Date

June 15, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

remodellingchronic cough

Outcome Measures

Primary Outcomes (3)

  • assessment of the severity of epithelial damage and inflammation in the bronchial biopsy

    Bronchial biopsy will be analysed for airway inflammation and remodeling features such as proportion of epithelial shedding basement membrane thickening, infiltration of inflammatory cells and subbasement membrane (SBM) thickening.

    baseline

  • assessment of airway inflammation and remodeling in the airways in chest CT

    The CT scans will be evaluated for the presence, extent, and severity of bronchial wall thickening, bronchiectasis, mucus plugs, centrilobular abnormalities, air trapping or mosaic attenuation.

    baseline

  • Assessment of biomarkers of inflammation in serum and BALF

    Assessment of cellular composition and inflammatory biomarkers in serum and BALF ( IL-2, IL4, IL-5, IL-8, PGE2, periostin, TSLP),

    baseline

Study Arms (1)

40 patients with refractory chronic cough lasting more than 6 months.

Patients were eligible for inclusion if they: were 18-75 years old; had chronic cough lasting more than 12 months unresponsive to previous treatment presented with a normal or near normal chest radiograph or only abnormalities irrelevant to cough; and had clinical indications for bronchoscopy

Diagnostic Test: chest computed tomography and bronchoscopy

Interventions

Assessment of airway remodeling features on chest CT in patients with chronic cough. Evaluation of airway injury and remodeling based on biological specimens obtained from the lower airways during bronchoscopy.Bronchoscopy is performed if clinically indicated.

Also known as: Assessment of airway remodeling features on chest computed tomography, Assessment of remodelling in bronchial biopsy or bronchoalveolar lavage fluid
40 patients with refractory chronic cough lasting more than 6 months.

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In 30 patients referred to the cough clinic for refractory chronic cough lasting more than 6 months

You may qualify if:

  • age between 18 and 75 years,
  • chronic cough of at least one year duration, with no previous treatment (at least 2 previous unsuccessful attempts at pharmacological treatment of cough)
  • negative history of smoking (at least 6 months of abstinence),
  • negative history of treatment with angiotensin-converting enzyme inhibitors (ACEI),
  • normal chest radiograph or with changes not relevant to cough formation,
  • no respiratory tract infections in the past 6 weeks,
  • written consent from the patient to participate in the study.

You may not qualify if:

  • patients less than 18 and more than 75 years of age,
  • cough lasting less than 12 months,
  • active smoking or abstinence period of less than 6 months,
  • cancer or interstitial lung disease,
  • contraindications to functional testing, sputum induction or bronchoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw

Warsaw, Masovian Voivodeship, 02-097, Poland

RECRUITING

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw

Warsaw, Warsaw, 02-097, Poland

RECRUITING

Medical University of Warsaw

Warsaw, 02-091, Poland

RECRUITING

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw

Warsaw, 02-097, Poland

RECRUITING

Related Publications (5)

  • Chung KF, McGarvey L, Song WJ, Chang AB, Lai K, Canning BJ, Birring SS, Smith JA, Mazzone SB. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022 Jun 30;8(1):45. doi: 10.1038/s41572-022-00370-w.

  • Macedo P, Zhang Q, Saito J, Liang Z, Ffolkes L, Nicholson AG, Chung KF. Analysis of bronchial biopsies in chronic cough. Respir Med. 2017 Jun;127:40-44. doi: 10.1016/j.rmed.2017.04.001. Epub 2017 Apr 4.

  • Gibson P, Wang G, McGarvey L, Vertigan AE, Altman KW, Birring SS; CHEST Expert Cough Panel. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report. Chest. 2016 Jan;149(1):27-44. doi: 10.1378/chest.15-1496. Epub 2016 Jan 6.

  • Dabrowska M, Grabczak EM, Arcimowicz M, Domeracka-Kolodziej A, Domagala-Kulawik J, Krenke R, Maskey-Warzechowska M, Tarchalska B, Chazan R. Causes of Chronic Cough in Non-smoking Patients. Adv Exp Med Biol. 2015;873:25-33. doi: 10.1007/5584_2015_153.

  • Irwin RS, French CL, Chang AB, Altman KW; CHEST Expert Cough Panel*. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report. Chest. 2018 Jan;153(1):196-209. doi: 10.1016/j.chest.2017.10.016. Epub 2017 Nov 10.

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood bronchoalveolat lavage fluid bronchial biopsy

MeSH Terms

Conditions

Chronic Cough

Interventions

Bronchoscopy

Condition Hierarchy (Ancestors)

CoughRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativePulmonary Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • Rafał Krenke, MD, PhD, Prof

    Department of Internal Medicine, Pulmonary Diseases and Allergy, Warsaw Medical University

    STUDY DIRECTOR

Central Study Contacts

Marta Dabrowska, MD, PhD

CONTACT

Karolina Klimowicz, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2026

First Posted

June 22, 2026

Study Start

October 1, 2022

Primary Completion

July 30, 2026

Study Completion (Estimated)

August 30, 2026

Last Updated

June 22, 2026

Record last verified: 2026-06

Locations